Close

Servier Exercises the Exclusive Worldwide License Option of Their Collaboration Program With Oncodesign Precision Medicine (OPM) on Parkinson's disease Sep 26, 2022 12:11PM
Oncodesign Precision Medicine (OPM) and Servier Announce a Strategic Collaboration to Discover New Therapeutic Targets for Pancreatic Cancer Treatment Sep 22, 2022 12:25PM
Oncodesign and Servier Reach a Key First Milestone in Their Strategic Partnership on LRRK2 Inhibitors for Parkinson’s Disease Feb 17, 2020 12:00PM
Parkinson's Disease: Servier and Oncodesign Join Forces to Investigate New Line of Research Mar 11, 2019 12:45PM
Oncodesign’s OncoSNIPE® Collaborative Programme Receives €7.7 Million in Support from the “Investments for the Future Programme” Operated by Bpifrance Feb 7, 2017 12:00PM